Discontinuation of anti-VEGF cancer therapy promotes metastasis through a liver revascularization mechanism

The impact of discontinuation of anti-VEGF cancer therapy in promoting cancer metastasis is unknown. Here we show discontinuation of anti-VEGF treatment creates a time-window of profound structural changes of liver sinusoidal vasculatures, exhibiting hyper-permeability and enlarged open-pore sizes o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nat Commun
Autors principals: Yang, Yunlong, Zhang, Yin, Iwamoto, Hideki, Hosaka, Kayoko, Seki, Takahiro, Andersson, Patrik, Lim, Sharon, Fischer, Carina, Nakamura, Masaki, Abe, Mitsuhiko, Cao, Renhai, Skov, Peter Vilhelm, Chen, Fang, Chen, Xiaoyun, Lu, Yongtian, Nie, Guohui, Cao, Yihai
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5025794/
https://ncbi.nlm.nih.gov/pubmed/27580750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ncomms12680
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars